Alan M Garber, M.D., Ph.D.

Concepts (567)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Cost-Benefit Analysis	62	2016	5265	1.760	Why?
Health Expenditures	17	2018	2270	1.730	Why?
Health Care Costs	18	2014	3164	1.170	Why?
Medicare	14	2018	5791	1.120	Why?
Comparative Effectiveness Research	4	2011	689	1.090	Why?
Technology Assessment, Biomedical	7	2007	302	1.080	Why?
Quality-Adjusted Life Years	29	2016	1626	0.810	Why?
Natural Language Processing	4	2009	953	0.760	Why?
Biomedical Technology	5	2006	219	0.760	Why?
Health Services Research	8	2009	1840	0.740	Why?
Diffusion of Innovation	4	2016	715	0.700	Why?
Colectomy	2	2012	650	0.610	Why?
Markov Chains	15	2016	985	0.580	Why?
Cost Control	4	2013	626	0.560	Why?
Economic Competition	2	2016	237	0.550	Why?
Defibrillators, Implantable	6	2010	1405	0.540	Why?
Mass Screening	18	2006	5209	0.530	Why?
Health Policy	10	2016	2649	0.520	Why?
Information Storage and Retrieval	3	2009	835	0.500	Why?
United States	63	2018	67905	0.500	Why?
Vaginal Smears	4	2001	499	0.480	Why?
Hypercholesterolemia	7	2000	1160	0.480	Why?
Industry	2	2006	367	0.470	Why?
Cholesterol	8	2000	2866	0.470	Why?
Sulfonylurea Compounds	2	2011	191	0.460	Why?
Multimedia	5	2005	72	0.460	Why?
Randomized Controlled Trials as Topic	11	2016	9596	0.450	Why?
Evidence-Based Medicine	6	2005	3683	0.450	Why?
Utilization Review	2	2005	401	0.440	Why?
Drug Industry	3	2009	902	0.440	Why?
Glucagon-Like Peptide 1	2	2011	315	0.430	Why?
Drug Approval	3	2009	899	0.430	Why?
Gaucher Disease	7	1998	113	0.430	Why?
Death, Sudden, Cardiac	3	2018	1502	0.420	Why?
Reimbursement, Incentive	4	2013	520	0.410	Why?
Mesalamine	1	2011	135	0.410	Why?
Colonic Pouches	1	2012	116	0.410	Why?
Kyphoplasty	1	2011	45	0.400	Why?
Coronary Disease	14	2000	6150	0.400	Why?
Health Care Reform	5	2016	1249	0.390	Why?
Azathioprine	1	2011	345	0.390	Why?
Technology, High-Cost	1	2010	32	0.390	Why?
Decision Making	4	2011	3846	0.390	Why?
Colitis, Ulcerative	2	2012	1824	0.380	Why?
Organizational Policy	5	2008	439	0.380	Why?
Vertebroplasty	1	2011	75	0.380	Why?
Androgen Antagonists	3	2012	1285	0.380	Why?
Low Back Pain	1	2018	934	0.380	Why?
Private Sector	3	2013	390	0.370	Why?
Academies and Institutes	1	2011	294	0.370	Why?
Health Services	3	2013	742	0.360	Why?
Watchful Waiting	2	2012	451	0.360	Why?
Osteoporosis	2	2011	1567	0.360	Why?
Insurance Coverage	4	2008	1863	0.360	Why?
Capsule Endoscopy	1	2009	90	0.350	Why?
Radiotherapy, Intensity-Modulated	2	2012	791	0.350	Why?
Decision Support Techniques	16	2014	2032	0.340	Why?
Glucosylceramidase	4	1994	129	0.340	Why?
Myocardial Infarction	10	2014	11401	0.340	Why?
Insurance Claim Reporting	2	2008	169	0.330	Why?
Fast Foods	1	2010	173	0.330	Why?
Hypoglycemic Agents	7	2014	2775	0.330	Why?
Taxes	1	2010	206	0.330	Why?
Tomography	1	2009	361	0.320	Why?
Preimplantation Diagnosis	1	2009	132	0.320	Why?
Device Approval	1	2010	197	0.320	Why?
Equipment and Supplies	2	2010	297	0.320	Why?
Heparin, Low-Molecular-Weight	2	1999	326	0.320	Why?
Decision Making, Organizational	2	2004	134	0.310	Why?
Humans	136	2018	715777	0.300	Why?
Cystic Fibrosis	3	2009	1133	0.300	Why?
Prostatectomy	2	2012	1796	0.300	Why?
Sodium, Dietary	1	2010	415	0.290	Why?
Pattern Recognition, Automated	2	2009	1019	0.290	Why?
Government Regulation	2	2010	546	0.280	Why?
Nutrition Policy	1	2010	472	0.280	Why?
Delivery of Health Care	4	2016	4881	0.280	Why?
Alendronate	1	2006	174	0.270	Why?
Models, Econometric	4	2011	220	0.260	Why?
Long-Term Care	2	2004	593	0.260	Why?
Efficiency	2	2008	491	0.260	Why?
Terminally Ill	1	2007	245	0.260	Why?
Diabetes Mellitus, Type 2	6	2014	11090	0.260	Why?
Pharmacogenetics	1	2009	699	0.260	Why?
Insurance, Health	4	2008	2497	0.260	Why?
Uterine Cervical Neoplasms	4	2001	1974	0.260	Why?
Costs and Cost Analysis	13	2010	1669	0.260	Why?
Spinal Fractures	1	2011	691	0.250	Why?
Teriparatide	1	2006	224	0.250	Why?
Antibodies, Monoclonal	3	2012	9548	0.250	Why?
Terminal Care	2	2007	1641	0.250	Why?
Insurance Claim Review	2	2008	750	0.250	Why?
Intestine, Small	1	2009	1221	0.240	Why?
Protein C	1	2003	151	0.240	Why?
Transcutaneous Electric Nerve Stimulation	1	2004	148	0.230	Why?
Heart Arrest	2	2003	1374	0.230	Why?
Activities of Daily Living	4	2008	2316	0.230	Why?
Disease	1	2008	705	0.230	Why?
Monte Carlo Method	5	2014	1306	0.220	Why?
Prostatic Neoplasms	4	2012	10605	0.220	Why?
Aged	48	2018	162448	0.220	Why?
Infertility, Female	1	2008	763	0.220	Why?
Tibial Fractures	1	2004	245	0.220	Why?
Heparin	2	1999	1620	0.210	Why?
Sensitivity and Specificity	20	2010	14902	0.210	Why?
Reimbursement Mechanisms	1	2007	658	0.210	Why?
Drug Costs	3	2013	1170	0.210	Why?
Orphan Drug Production	2	1992	67	0.210	Why?
Quality of Life	11	2012	11721	0.210	Why?
Blood Glucose	4	2014	6259	0.210	Why?
Orchiectomy	2	2000	453	0.210	Why?
Research Support as Topic	3	2011	725	0.210	Why?
Terminology as Topic	1	2008	1612	0.200	Why?
Patient-Centered Care	1	2011	1460	0.200	Why?
Angioplasty	2	2014	374	0.200	Why?
Aircraft	1	2001	115	0.200	Why?
Laparoscopy	2	2011	1980	0.200	Why?
Diethylstilbestrol	1	2000	92	0.200	Why?
Streptococcus agalactiae	1	2002	373	0.200	Why?
Endometriosis	1	2008	803	0.200	Why?
Diagnostic Techniques and Procedures	1	2002	203	0.200	Why?
Drug Discovery	1	2009	1060	0.200	Why?
Financing, Personal	2	2013	313	0.200	Why?
Influenza Vaccines	3	2014	689	0.200	Why?
Practice Guidelines as Topic	5	2005	7446	0.190	Why?
California	8	2008	1396	0.190	Why?
Pharmaceutical Preparations	1	2009	1042	0.190	Why?
Thiazolidinediones	2	2014	484	0.190	Why?
Influenza, Human	4	2014	1388	0.190	Why?
Body Weight	1	2011	4688	0.190	Why?
Venous Thrombosis	2	1999	1216	0.190	Why?
Models, Economic	3	2013	719	0.190	Why?
Intensive Care Units	3	2008	3451	0.180	Why?
Cataract Extraction	1	2003	457	0.170	Why?
Managed Care Programs	1	2004	985	0.170	Why?
Biological Products	1	2007	838	0.170	Why?
Bone Density Conservation Agents	1	2006	785	0.170	Why?
Ultraviolet Therapy	1	1998	81	0.170	Why?
Mass Vaccination	2	2009	108	0.170	Why?
Anticoagulants	4	2016	4375	0.170	Why?
Electric Countershock	1	2001	515	0.170	Why?
Research	3	2011	2016	0.170	Why?
Caregivers	2	2011	1925	0.170	Why?
Streptococcal Infections	1	2002	645	0.160	Why?
Pregnancy Outcome	1	2008	2719	0.160	Why?
Female	61	2018	377204	0.160	Why?
Health Care Rationing	1	2001	457	0.160	Why?
Healthcare Disparities	1	2013	3035	0.160	Why?
Male	57	2018	350324	0.160	Why?
Osteogenesis	1	2004	1277	0.160	Why?
Age Factors	9	2018	18784	0.160	Why?
Life Expectancy	6	2013	1143	0.150	Why?
Receptor, erbB-2	1	2007	2313	0.150	Why?
Interviews as Topic	5	2005	2596	0.150	Why?
Crohn Disease	1	2009	2256	0.150	Why?
Artificial Intelligence	1	2008	1744	0.150	Why?
State Medicine	2	2008	206	0.150	Why?
Government Agencies	1	1996	163	0.150	Why?
Attitude to Health	3	2008	2110	0.150	Why?
Decision Trees	6	2016	523	0.150	Why?
Quality Assurance, Health Care	4	2008	2260	0.140	Why?
Disease Outbreaks	3	2010	1741	0.140	Why?
Stroke	5	2016	9505	0.140	Why?
Survival Analysis	7	2007	10499	0.140	Why?
Financing, Government	2	2009	485	0.140	Why?
Publishing	1	2002	805	0.130	Why?
Geriatric Assessment	5	2008	1312	0.130	Why?
Antineoplastic Agents, Hormonal	2	2000	1536	0.130	Why?
Dermatologic Agents	1	1998	298	0.130	Why?
Medical Informatics	1	2002	737	0.130	Why?
Polymerase Chain Reaction	2	2002	6274	0.130	Why?
Quality of Health Care	3	2010	4282	0.130	Why?
Software	5	2008	4396	0.130	Why?
Recombinant Proteins	2	2007	6803	0.130	Why?
Hyperlipidemias	2	2002	803	0.130	Why?
Hospitals, Veterans	1	1996	403	0.130	Why?
Treatment Outcome	18	2014	62004	0.120	Why?
Visual Acuity	1	2003	2490	0.120	Why?
Socioeconomic Factors	4	2018	7757	0.120	Why?
Academic Medical Centers	1	2004	2789	0.120	Why?
Tomography, Emission-Computed, Single-Photon	1	1999	1181	0.120	Why?
United States Department of Veterans Affairs	2	2006	857	0.120	Why?
Health Services for the Aged	2	2004	263	0.120	Why?
Hypolipidemic Agents	1	1998	617	0.120	Why?
Coronary Angiography	2	2010	4410	0.120	Why?
Renal Dialysis	3	2008	1744	0.120	Why?
Brachytherapy	2	2012	1282	0.120	Why?
Anti-Inflammatory Agents, Non-Steroidal	1	2003	2280	0.120	Why?
Middle Aged	33	2013	214639	0.120	Why?
Anticholesteremic Agents	1	2000	960	0.120	Why?
Survivors	1	2003	2171	0.110	Why?
Hospital Costs	3	2007	976	0.110	Why?
Estrogen Replacement Therapy	2	2002	1185	0.110	Why?
Atrial Appendage	1	2016	257	0.110	Why?
Attitude to Computers	2	2005	199	0.110	Why?
Risk Factors	20	2018	70866	0.110	Why?
Public Policy	1	1996	556	0.110	Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors	2	2013	3149	0.110	Why?
Prenatal Diagnosis	2	1991	1179	0.110	Why?
Hospitals	1	2005	3375	0.110	Why?
Cost of Illness	4	2012	1840	0.110	Why?
Human Growth Hormone	2	2008	701	0.110	Why?
Methotrexate	1	1998	1725	0.110	Why?
Rhabdomyolysis	1	2013	157	0.110	Why?
American Recovery and Reinvestment Act	1	2011	66	0.110	Why?
Health Status Indicators	3	2008	986	0.100	Why?
Patient Satisfaction	3	2011	3398	0.100	Why?
Choice Behavior	1	1997	794	0.100	Why?
Geography	1	2013	691	0.100	Why?
Genetic Testing	3	2006	3350	0.100	Why?
Pravastatin	1	2013	390	0.100	Why?
Coronary Artery Bypass	3	2014	2397	0.100	Why?
Health Services Accessibility	2	2005	5038	0.100	Why?
Pregnancy Complications, Infectious	1	2002	2034	0.100	Why?
beta-Alanine	1	2010	76	0.100	Why?
Aged, 80 and over	13	2018	58323	0.100	Why?
Combined Modality Therapy	2	2014	8890	0.100	Why?
Life Support Care	1	2011	220	0.100	Why?
Psoriasis	1	1998	974	0.100	Why?
Adult	29	2010	212266	0.090	Why?
Carotid Stenosis	1	1997	812	0.090	Why?
Nephrons	1	2011	197	0.090	Why?
Cerebrovascular Disorders	1	1997	1507	0.090	Why?
United States Food and Drug Administration	2	2010	1778	0.090	Why?
Jurisprudence	1	2010	118	0.090	Why?
Sepsis	1	2003	2465	0.090	Why?
Sex Factors	5	2018	10666	0.090	Why?
Expressed Emotion	1	2010	96	0.090	Why?
Eligibility Determination	1	2013	386	0.090	Why?
Equipment Failure	2	2010	579	0.090	Why?
African Americans	1	2005	5003	0.090	Why?
Breast Neoplasms	2	2007	20062	0.090	Why?
Subject Headings	1	2008	20	0.090	Why?
Public Health	1	2002	2430	0.090	Why?
Therapeutic Equivalency	1	2009	158	0.090	Why?
Risk	3	2018	9801	0.090	Why?
Influenza A Virus, H5N1 Subtype	1	2009	114	0.090	Why?
Electrocardiography	3	1999	6386	0.090	Why?
Antihypertensive Agents	2	1998	2058	0.090	Why?
Physicians	2	2004	4375	0.090	Why?
Object Attachment	1	2011	305	0.090	Why?
Diabetes Complications	2	2014	1397	0.090	Why?
Probability	3	2003	2487	0.090	Why?
Residence Characteristics	1	2018	2003	0.090	Why?
Diet, Sodium-Restricted	1	2010	272	0.080	Why?
Psychometrics	1	1998	2971	0.080	Why?
Pregnancy, Multiple	1	2009	219	0.080	Why?
Drug Resistance, Microbial	2	1989	877	0.080	Why?
Observation	1	2010	315	0.080	Why?
Standard of Care	1	2011	522	0.080	Why?
Hypoglycemia	2	2010	813	0.080	Why?
Twins	1	2009	354	0.080	Why?
Athletic Performance	1	2008	92	0.080	Why?
Coronary Artery Disease	3	2014	6289	0.080	Why?
Gastrointestinal Agents	1	2012	493	0.080	Why?
Multivariate Analysis	5	2005	12480	0.080	Why?
Exercise Test	2	1999	2110	0.080	Why?
Drugs, Generic	2	2014	520	0.080	Why?
Decision Making, Computer-Assisted	2	1998	162	0.070	Why?
Logistic Models	4	2010	13618	0.070	Why?
Warfarin	2	2016	1476	0.070	Why?
Forecasting	3	2011	2956	0.070	Why?
Smoking Cessation	1	1998	2030	0.070	Why?
Echocardiography	1	1999	5044	0.070	Why?
Canada	2	2008	1967	0.070	Why?
Pregnancy Rate	1	2009	599	0.070	Why?
Computer Literacy	2	2005	43	0.070	Why?
Kidney Failure, Chronic	3	2013	2548	0.070	Why?
Blastocyst	1	2009	433	0.070	Why?
Hospitalization	4	2013	9745	0.070	Why?
Health Services Needs and Demand	2	2004	1437	0.070	Why?
Public Sector	1	2007	266	0.070	Why?
Evaluation Studies as Topic	2	2007	1738	0.070	Why?
Anthrax Vaccines	1	2005	14	0.070	Why?
Exercise	4	2008	5427	0.070	Why?
Atrial Fibrillation	2	2016	4562	0.070	Why?
Heart Diseases	3	2002	2755	0.070	Why?
Influenza A Virus, H1N1 Subtype	1	2009	472	0.070	Why?
Clinical Trials as Topic	5	2014	7960	0.070	Why?
Incidental Findings	1	2010	676	0.070	Why?
Nephrectomy	1	2011	1004	0.070	Why?
Benzimidazoles	1	2010	877	0.070	Why?
Ischemic Attack, Transient	1	2010	907	0.070	Why?
Disease Progression	4	2013	13215	0.070	Why?
Abortion, Spontaneous	1	2009	475	0.070	Why?
Geriatric Nursing	1	2005	39	0.070	Why?
Algorithms	4	2009	13758	0.070	Why?
Anthrax	1	2005	101	0.070	Why?
Clinical Protocols	1	1991	1473	0.060	Why?
Recurrence	4	2000	8240	0.060	Why?
Computer Simulation	2	2010	6105	0.060	Why?
Health Facility Merger	1	2004	48	0.060	Why?
Models, Cardiovascular	1	2010	1002	0.060	Why?
Direct Service Costs	2	2014	64	0.060	Why?
Bioterrorism	1	2005	149	0.060	Why?
Regression Analysis	2	2010	6495	0.060	Why?
Rate Setting and Review	1	2004	41	0.060	Why?
Double-Blind Method	3	2011	11945	0.060	Why?
Adjuvants, Immunologic	1	2009	975	0.060	Why?
Molecular Diagnostic Techniques	1	2009	622	0.060	Why?
Economics	1	2004	148	0.060	Why?
Diagnostic Imaging	1	2018	3494	0.060	Why?
Physician Executives	1	2004	136	0.060	Why?
Antipsychotic Agents	1	1997	3062	0.060	Why?
Capitation Fee	1	2004	117	0.060	Why?
Japan	1	2008	1341	0.060	Why?
Gonadotropin-Releasing Hormone	2	2000	1191	0.060	Why?
Cardiovascular Diseases	1	2009	14438	0.060	Why?
Hypertension	4	2013	8270	0.060	Why?
Product Surveillance, Postmarketing	1	2008	498	0.060	Why?
Commerce	1	2009	602	0.060	Why?
Time Factors	6	2013	40875	0.060	Why?
Patient Care	1	2009	620	0.060	Why?
APACHE	1	2003	270	0.060	Why?
Models, Theoretical	3	2014	3580	0.060	Why?
Boronic Acids	1	2007	971	0.060	Why?
Drug Administration Schedule	2	2007	5031	0.060	Why?
Pregnancy	4	2009	27398	0.060	Why?
Heart Valve Prosthesis Implantation	1	2013	1484	0.060	Why?
Genes, BRCA2	1	2006	592	0.060	Why?
Cohort Studies	5	2007	40029	0.060	Why?
New York City	1	2004	663	0.060	Why?
Heterozygote	1	2009	2794	0.060	Why?
Fee-for-Service Plans	2	2004	652	0.050	Why?
National Institutes of Health (U.S.)	3	1996	763	0.050	Why?
Developed Countries	1	2004	409	0.050	Why?
Genes, BRCA1	1	2006	760	0.050	Why?
Myocardial Revascularization	2	2003	847	0.050	Why?
Affect	1	2010	1494	0.050	Why?
Social Responsibility	1	2005	393	0.050	Why?
Tomography, X-Ray Computed	2	2010	20356	0.050	Why?
Mortality	3	1999	2837	0.050	Why?
Patient Protection and Affordable Care Act	1	2011	1167	0.050	Why?
Pyrazines	1	2007	1246	0.050	Why?
Reproducibility of Results	7	2005	19537	0.050	Why?
Aortic Valve Stenosis	1	2013	1844	0.050	Why?
Patient Selection	2	2013	4293	0.050	Why?
Fertilization in Vitro	1	2009	1255	0.050	Why?
Platelet Aggregation Inhibitors	1	2014	3014	0.050	Why?
Europe	1	2008	3343	0.050	Why?
Drug Therapy, Combination	2	2014	6552	0.050	Why?
Bacterial Infections	1	1989	1425	0.050	Why?
Acute Coronary Syndrome	1	2014	2263	0.050	Why?
Fibrinolytic Agents	1	2010	2124	0.050	Why?
Cross Infection	1	1989	1409	0.050	Why?
Bacteria	2	1989	2115	0.050	Why?
Medicare Part C	1	2004	251	0.050	Why?
Anti-Bacterial Agents	2	1989	7095	0.050	Why?
Radiography	2	2009	6978	0.050	Why?
Labor, Obstetric	1	2002	316	0.050	Why?
Data Collection	2	2002	3317	0.050	Why?
Survival Rate	4	2016	13206	0.050	Why?
Antibiotic Prophylaxis	1	2005	628	0.050	Why?
Ventricular Fibrillation	1	2002	534	0.050	Why?
Sex Distribution	1	2005	2371	0.050	Why?
Thallium Radioisotopes	1	1999	148	0.050	Why?
Diabetes Mellitus, Type 1	1	1994	3375	0.050	Why?
Hospitals, Teaching	1	1984	1153	0.040	Why?
Analysis of Variance	2	1999	6501	0.040	Why?
Dipyridamole	1	1999	154	0.040	Why?
Dobutamine	1	1999	126	0.040	Why?
Acute Disease	2	2008	7140	0.040	Why?
Magnetic Resonance Imaging	1	2006	34430	0.040	Why?
Hemorrhage	3	2014	3279	0.040	Why?
Self Concept	1	2005	1029	0.040	Why?
Benchmarking	1	2005	927	0.040	Why?
Technetium Tc 99m Sestamibi	1	1999	191	0.040	Why?
Schizophrenia	1	1997	6702	0.040	Why?
Histamine H2 Antagonists	1	2000	169	0.040	Why?
Synostosis	1	1998	39	0.040	Why?
Nursing Homes	1	2006	967	0.040	Why?
Needs Assessment	1	2004	1147	0.040	Why?
Cities	2	2014	498	0.040	Why?
Chemotherapy, Adjuvant	1	2007	3551	0.040	Why?
Comorbidity	2	2013	10435	0.040	Why?
Catheter Ablation	1	2011	2558	0.040	Why?
Akathisia, Drug-Induced	1	1997	68	0.040	Why?
Postoperative Period	1	2003	1843	0.040	Why?
Image Processing, Computer-Assisted	2	2009	9004	0.040	Why?
Primary Prevention	2	2013	1161	0.040	Why?
Predictive Value of Tests	3	2002	15199	0.040	Why?
Incidence	3	2013	20731	0.040	Why?
Tachycardia, Ventricular	2	2002	1214	0.040	Why?